A case of post‐COVID‐19 myalgic encephalomyelitis/chronic fatigue syndrome characterized by post‐exertional malaise and low serum acylcarnitine level

A case of post‐COVID‐19 myalgic encephalomyelitis/chronic fatigue syndrome characterized by post‐exertional malaise and low serum acylcarnitine level

Abstract COVID‐19 afflicts patients with acute symptoms and longer term sequelae. One of the sequelae is myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), which is often difficult to diagnose, having no established tests. In this article, we synthesize information from literature reviews...

Full description

Bibliographic Details
Main Authors: Ryuhei Jinushi, Sho Nishiguchi, Sakue Masuda, Akiko Sasaki, Kazuya Koizumi, Shomei Ryozawa
Format: Article
Language:English
Published: Wiley 2023-02-01
Series:Clinical Case Reports
Subjects:
acylcarnitine
COVID‐19
fatigue syndrome
malaise
Online Access:https://doi.org/10.1002/ccr3.6930

Internet

https://doi.org/10.1002/ccr3.6930

Similar Items